Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Current Assets: 2022-2024

Historic Current Assets for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $309.9 million.

  • Gossamer Bio's Current Assets fell 40.75% to $204.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.0 million, marking a year-over-year decrease of 40.75%. This contributed to the annual value of $309.9 million for FY2024, which is 1.10% up from last year.
  • Latest data reveals that Gossamer Bio reported Current Assets of $309.9 million as of FY2024, which was up 1.10% from $306.5 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Current Assets registered a high of $309.9 million during FY2024, and its lowest value of $261.9 million during FY2022.
  • Its 3-year average for Current Assets is $292.8 million, with a median of $306.5 million in 2023.
  • Data for Gossamer Bio's Current Assets shows a peak YoY increased of 17.05% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Gossamer Bio's Current Assets stood at $261.9 million in 2022, then rose by 17.05% to $306.5 million in 2023, then rose by 1.10% to $309.9 million in 2024.